The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT05803759

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05803759
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05803759. Randomized; double masking; primary purpose treatment. Start 2023-04-10 (actual); primary completion 2024-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment
Acronym
TEA-CART
Condition
Myocardial Ischemia
Condition
Coronary Arteriosclerosis
Condition
Percutaneous Coronary Revascularization
Intervention (Dietary supplement)
Allicor
Intervention (Drug)
Placebo
Lead sponsor
Institute for Atherosclerosis Research, Russia (class: other)

Record details

Record id
cardio:ct-nct05803759
Content hash
0c79fd7f3877e4313393c310b62396a9ecb3568704eaa84eca4112feba53a542